Seminars in Hematology
Volume 44 , Pages S16-S20 , April 2007

Clinical Evaluation of Deferasirox (Exjade®, ICL670)

  • John Porter

      Affiliations

    • Corresponding Author InformationAddress correspondence to Professor John B Porter, MA, MD, FRCP, FRCPath, Department of Haematology, University College London, 98 Chenies Mews, London WC1E 6HX, UK.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0037-1963(07)00055-8

doi: 10.1053/j.seminhematol.2007.03.004

Seminars in Hematology
Volume 44 , Pages S16-S20 , April 2007

Article Tools

* Image Usage & Resolution